https://www.acplgroupindia.in
91

6. However, accelerated approval should be used for a drug that represent significant adva...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

2.0 Device description and product specification, including variants and accessories 2.1 T...

View more

2.0 Device description and product specification, including variants and accessories 2.1 T...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

Such discussion to help the reviewers becomes acquainted with the information to be includ...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

Subscribe for latest offers and updates.

we hate spam too